Table 1.
ID | Cell line | Mouse NO. | GSI treatment | Ascites | Tumor | Survival time (d) |
---|---|---|---|---|---|---|
A1 | BJAB | 1 | − | + | + | 46 |
A2 | BJAB | 2 | − | + | + | 51 |
A3 | BJAB | 3 | − | + | + | 56 |
A4 | BJAB | 4 | − | + | + | 72 |
A5 | BJAB | 5 | − | + | + | 55 |
A6 | BJAB | 6 | − | + | + | 50 |
A7 | BJAB | 7 | − | + | + | 71 |
A8 | BJAB | 8 | − | + | + | 47 |
A9 | BJAB | 1 | + | + | + | 74 |
A10 | BJAB | 2 | + | + | + | 50 |
A11 | BJAB | 3 | + | + | + | 42 |
A12 | BJAB | 4 | + | + | + | 52 |
A13 | BJAB | 5 | + | + | + | 44 |
A14 | BJAB | 6 | + | + | + | 48 |
A15 | BJAB | 7 | + | + | + | 53 |
A16 | BJAB | 8 | + | + | + | 71 |
A17 | 1 | − | + | + | 48 | |
A18 | 2 | − | + | + | 42 | |
A19 | 3 | − | + | + | 47 | |
4 | − | + | + | 42 | ||
A21 | 5 | − | + | + | 50 | |
6 | − | + | + | 47 | ||
7 | − | + | + | 48 | ||
8 | − | + | + | 50 | ||
1 | + | + | + | 60 | ||
2 | + | + | + | 51 | ||
3 | + | + | + | 44 | ||
4 | + | + | + | 70 | ||
5 | + | + | + | 66 | ||
6 | + | + | + | 59 | ||
A31 | 7 | + | + | + | 66 | |
8 | + | + | + | 69 | ||
JSC1 | 1 | − | + | + | 23 | |
JSC1 | 2 | − | + | + | 24 | |
JSC1 | 3 | − | + | + | 21 | |
JSC1 | 4 | − | + | + | 24 | |
JSC1 | 5 | − | + | + | 21 | |
JSC1 | 6 | − | + | + | 23 | |
JSC1 | 7 | − | + | + | 25 | |
JSC1 | 8 | − | + | + | 25 | |
A41 | JSC1 | 1 | + | + | + | 21 |
A42 | JSC1 | 2 | + | + | + | 26 |
A43 | JSC1 | 3 | + | + | + | 29 |
JSC1 | 4 | + | + | + | 27 | |
JSC1 | 5 | + | + | + | 23 | |
JSC1 | 6 | + | + | + | 31 | |
A47 | JSC1 | 7 | + | + | + | 44 |
JSC1 | 8 | + | + | + | 48 |